Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Souery

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
The American Journal of Psychiatry|July 15, 2014
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptylineRudolf Uher, Katherine E Tansey, Tracy Dew, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 26, 2019
Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practiceLucie Bartova, Markus Dold, Alexander Kautzky, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2004
Expanded RED products and loci containing CAG/CTG repeats on chromosome 17 (ERDA1) and chromosome 18 (CTG18.1) in trans-generational pairs with bipolar affective disorderJulien Mendlewicz, Daniel Souery, Jurgen Del-Favero, et al.
The Journal of Clinical Psychiatry|January 10, 2017
A New Prediction Model for Evaluating Treatment-Resistant DepressionAlexander Kautzky, Pia Baldinger-Melich, Georg S Kranz, et al.
Journal of Affective Disorders|June 13, 2015
Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depressionLeonardo Zaninotto, Daniel Souery, Raffaella Calati, et al.
Journal of Psychiatric Research|July 3, 2021
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant DepressionLucie Bartova, Gernot Fugger, Markus Dold, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 20, 2023
Age as a moderating factor of treatment resistance in depressionAlexander Kautzky, Lucie Bartova, Gernot Fugger, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter studyDaniel Souery, Pierre Oswald, Isabelle Massat, et al.
The International Journal of Neuropsychopharmacology|October 5, 2017
The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter StudyAlexandra Schosser, Laura Carlberg, Raffaella Calati, et al.
Comprehensive Psychiatry|October 26, 2013
Family history of major depression and residual symptoms in responder and non-responder depressed patientsAlessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
The American Journal of Psychiatry|July 15, 2014
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptylineRudolf Uher, Katherine E Tansey, Tracy Dew, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 26, 2019
Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practiceLucie Bartova, Markus Dold, Alexander Kautzky, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2004
Expanded RED products and loci containing CAG/CTG repeats on chromosome 17 (ERDA1) and chromosome 18 (CTG18.1) in trans-generational pairs with bipolar affective disorderJulien Mendlewicz, Daniel Souery, Jurgen Del-Favero, et al.
The Journal of Clinical Psychiatry|January 10, 2017
A New Prediction Model for Evaluating Treatment-Resistant DepressionAlexander Kautzky, Pia Baldinger-Melich, Georg S Kranz, et al.
Journal of Affective Disorders|June 13, 2015
Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depressionLeonardo Zaninotto, Daniel Souery, Raffaella Calati, et al.
Journal of Psychiatric Research|July 3, 2021
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant DepressionLucie Bartova, Gernot Fugger, Markus Dold, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 20, 2023
Age as a moderating factor of treatment resistance in depressionAlexander Kautzky, Lucie Bartova, Gernot Fugger, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter studyDaniel Souery, Pierre Oswald, Isabelle Massat, et al.
The International Journal of Neuropsychopharmacology|October 5, 2017
The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter StudyAlexandra Schosser, Laura Carlberg, Raffaella Calati, et al.
Comprehensive Psychiatry|October 26, 2013
Family history of major depression and residual symptoms in responder and non-responder depressed patientsAlessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
Pageof 17